Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects
(greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA
criteria) having full thickness (i.e., through the dermis but not involving joint capsule,
tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and
meet all other entry criteria to be enrolled and receive PluroGel PN.